Why gene and cell therapies are stalling at the FDA A wave of FDA rejections reveals how CMC issues are becoming a leading barrier to approval in advanced therapy development.

https://www.drugdiscoverynews.com/why-gene-and-cell-therapies-are-stalling-at-the-fda-16527